Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1992 Jun;67(6):450–453. doi: 10.1136/hrt.67.6.450

Failure of balloon dilatation of the pulmonary valve in carcinoid pulmonary stenosis.

S C Grant 1, J H Scarffe 1, R D Levy 1, N H Brooks 1
PMCID: PMC1024885  PMID: 1622693

Abstract

BACKGROUND--Carcinoid heart disease typically results in pulmonary stenosis and tricuspid incompetence. Percutaneous balloon dilatation is an effective treatment for congenital pulmonary stenosis and has been applied successfully to tricuspid stenosis caused by carcinoid heart disease. The value of balloon dilatation of the pulmonary valve in carcinoid pulmonary stenosis was assessed. METHODS--Two patients with severe congestive heart failure secondary to carcinoid heart disease and with documented pulmonary stenosis had balloon dilatation of the pulmonary valve. In both cases tricuspid regurgitation was also present together with reduced cardiac output. RESULTS--The procedure was technically successful in both patients. One patient experienced symptomatic benefit for two months and the other experienced no improvement. Both patients subsequently required combined tricuspid and pulmonary valve replacement from which good results and symptomatic improvement were obtained. CONCLUSION--Though balloon dilatation of the pulmonary valve is technically feasible it is unlikely to provide useful palliation in carcinoid heart disease. Valve surgery should be considered in patients in whom the malignancy is controlled but carcinoid heart disease is producing drug resistant congestive heart failure.

Full text

PDF
450

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arora R. R., Warner R. R. Do indole markers predict carcinoid heart disease? Chest. 1986 Jul;90(1):87–89. doi: 10.1378/chest.90.1.87. [DOI] [PubMed] [Google Scholar]
  2. Cheng T. O. Nonsurgical treatment of carcinoid heart disease. Ann Thorac Surg. 1991 Jun;51(6):1046–1047. doi: 10.1016/0003-4975(91)91057-3. [DOI] [PubMed] [Google Scholar]
  3. Ferrans V. J., Roberts W. C. The carcinoid endocardial plaque; an ultrastructural study. Hum Pathol. 1976 Jul;7(4):387–409. doi: 10.1016/s0046-8177(76)80054-8. [DOI] [PubMed] [Google Scholar]
  4. Fetherston G. J., Davis B. B. Surgical management of carcinoid heart disease. Ann Thorac Surg. 1991 Mar;51(3):493–494. doi: 10.1016/0003-4975(91)90879-u. [DOI] [PubMed] [Google Scholar]
  5. Fontes V. F., Sousa J. E., Esteves C. A., Silva M. V., Cano M. N., Maldonado G. Pulmonary valvoplasty--experience of 100 cases. Int J Cardiol. 1988 Dec;21(3):335–342. doi: 10.1016/0167-5273(88)90110-6. [DOI] [PubMed] [Google Scholar]
  6. Himelman R. B., Schiller N. B. Clinical and echocardiographic comparison of patients with the carcinoid syndrome with and without carcinoid heart disease. Am J Cardiol. 1989 Feb 1;63(5):347–352. doi: 10.1016/0002-9149(89)90344-5. [DOI] [PubMed] [Google Scholar]
  7. Kvols L. K., Moertel C. G., O'Connell M. J., Schutt A. J., Rubin J., Hahn R. G. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med. 1986 Sep 11;315(11):663–666. doi: 10.1056/NEJM198609113151102. [DOI] [PubMed] [Google Scholar]
  8. Lundin L., Funa K., Hansson H. E., Wilander E., Oberg K. Histochemical and immunohistochemical morphology of carcinoid heart disease. Pathol Res Pract. 1991 Jan;187(1):73–77. doi: 10.1016/S0344-0338(11)81048-4. [DOI] [PubMed] [Google Scholar]
  9. Lundin L., Hansson H. E., Landelius J., Oberg K. Surgical treatment of carcinoid heart disease. J Thorac Cardiovasc Surg. 1990 Oct;100(4):552–561. [PubMed] [Google Scholar]
  10. Lundin L., Landelius J., Andrén B., Oberg K. Transoesophageal echocardiography improves the diagnostic value of cardiac ultrasound in patients with carcinoid heart disease. Br Heart J. 1990 Sep;64(3):190–194. doi: 10.1136/hrt.64.3.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lundin L., Norheim I., Landelius J., Oberg K., Theodorsson-Norheim E. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities. Circulation. 1988 Feb;77(2):264–269. doi: 10.1161/01.cir.77.2.264. [DOI] [PubMed] [Google Scholar]
  12. Lundin L., Norheim I., Landelius J., Oberg K., Theodorsson-Norheim E. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities. Circulation. 1988 Feb;77(2):264–269. doi: 10.1161/01.cir.77.2.264. [DOI] [PubMed] [Google Scholar]
  13. McKinney B., Crawford M. A. Fibrosis in guineapig heart produced by plantain diet. Lancet. 1965 Oct 30;2(7418):880–882. doi: 10.1016/s0140-6736(65)92506-7. [DOI] [PubMed] [Google Scholar]
  14. Moertel C. G. Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol. 1983 Nov;1(11):727–740. doi: 10.1200/JCO.1983.1.11.727. [DOI] [PubMed] [Google Scholar]
  15. Mullins P. A., Hall J. A., Shapiro L. M. Balloon dilatation of tricuspid stenosis caused by carcinoid heart disease. Br Heart J. 1990 Apr;63(4):249–250. doi: 10.1136/hrt.63.4.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Oberg K., Norheim I., Lind E., Alm G., Lundqvist G., Wide L., Jonsdottir B., Magnusson A., Wilander E. Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results. Cancer Treat Rep. 1986 Nov;70(11):1297–1304. [PubMed] [Google Scholar]
  17. ROBERTS W. C., SJOERDSMA A. THE CARDIAC DISEASE ASSOCIATED WITH THE CARCINOID SYNDROME (CARCINOID HEART DISEASE). Am J Med. 1964 Jan;36:5–34. doi: 10.1016/0002-9343(64)90145-7. [DOI] [PubMed] [Google Scholar]
  18. Ross E. M., Roberts W. C. The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease. Am J Med. 1985 Sep;79(3):339–354. doi: 10.1016/0002-9343(85)90313-4. [DOI] [PubMed] [Google Scholar]
  19. Strickman N. E., Rossi P. A., Massumkhani G. A., Hall R. J. Carcinoid heart disease: a clinical pathologic, and therapeutic update. Curr Probl Cardiol. 1982 Feb;6(11):1–42. doi: 10.1016/0146-2806(82)90013-5. [DOI] [PubMed] [Google Scholar]
  20. THORSON A., BIORCK G., BJORKMAN G., WALDENSTROM J. Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis; a clinical and pathologic syndrome. Am Heart J. 1954 Jun;47(5):795–817. doi: 10.1016/0002-8703(54)90152-0. [DOI] [PubMed] [Google Scholar]
  21. Trell E., Rausing A., Ripa J., Torp A., Waldenström J. Carcinoid heart disease. Clinicopathologic findings and follow-up in 11 cases. Am J Med. 1973 Apr;54(4):433–444. doi: 10.1016/0002-9343(73)90039-9. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES